
Alprotic 133.5mg/58mg Tablet CR
Marketer
Cubit Healthcare
Salt Composition
Sodium Valproate (133.5mg) + Valproic Acid (58mg)
Overview Alprotic 133.5mg/58mg Tablet CR
Epileptic seizures, characterized by recurrent fits stemming from abnormal brain activity, are effectively managed by the dual-action medication, Alprotic 133.5mg/58mg CR tablets. This formulation calms neuronal overactivity, thus preventing seizure episodes. Administer Alprotic with food, following your physician's prescribed dosage regimen. Dosage may gradually increase to optimize seizure control. While therapeutic effects may take several weeks, consistent use is crucial. Discontinuation should only occur under medical supervision as abrupt cessation can trigger increased seizures or exacerbate bipolar symptoms if present. Commonly reported side effects include nausea and tremors; less frequent adverse reactions encompass vomiting, headache, hepatic impairment, and epigastric pain. Most side effects are transient, but persistent or bothersome effects warrant immediate medical consultation. Prior to initiating Alprotic, disclose any pre-existing renal or hepatic dysfunction, meningitis, depression, or suicidal ideation. Comprehensive medication disclosure is necessary, as drug interactions may occur with other medications, including hormonal contraceptives. Alprotic use during pregnancy or lactation requires careful medical evaluation and potential dosage adjustments based on clinical need. Drowsiness or dizziness mandates abstention from driving or cycling. Regular blood monitoring assesses treatment efficacy. Alcohol consumption should be avoided due to potential exacerbation of side effects. Weight gain is a potential side effect; maintaining a balanced diet, limiting high-calorie snacks, and regular exercise are recommended. Report any unusual mood or behavioral changes, including new or worsening depressive symptoms or suicidal thoughts or actions, promptly to your doctor.
Primary Ingredients of Alprotic 133.5mg/58mg Tablet CR
No information provided. Please provide the text you wish me to rephrase.
Uses of Alprotic 133.5mg/58mg Tablet CR
Seizure disorder
Major Benefits of Alprotic 133.5mg/58mg Tablet CR:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the entire tablet; avoid chewing, crushing, or breaking it. Consume Alprotic 133.5mg/58mg CR tablets with a meal.
Common Side effects of Alprotic 133.5mg/58mg Tablet CR:
- Nausea
- Tremors
How to use Alprotic 133.5mg/58mg Tablet CR:
Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment period. Ingest the Alprotic 133.5mg/58mg CR tablet whole; avoid chewing, crushing, or fracturing it. This medication should be administered with a meal.
How Alprotic 133.5mg/58mg Tablet CR works:
The extended-release tablet, Alprotic CR, contains 133.5mg of sodium valproate and 58mg of valproic acid, both anticonvulsant agents.
SAFETY ADVICE
AlcoholUNSAFE
Combining Alprotic 133.5mg/58mg CR tablets with alcohol is hazardous.
PregnancyCONSULT YOUR DOCTOR
The extended-release Alprotic 133.5mg/58mg tablet is contraindicated during pregnancy due to confirmed fetal risk. In exceptional, life-threatening circumstances, a physician might prescribe it if the potential benefits outweigh the hazards. Physician consultation is essential.
Breast feedingSAFE IF PRESCRIBED
Alprotic 133.5mg/58mg extended-release tablets are considered safe for breastfeeding mothers. Research in humans indicates minimal drug transfer to breast milk, posing no known risk to the infant.
DrivingUNSAFE
Taking Alprotic 133.5mg/58mg CR tablets might cause drowsiness, blurred vision, and dizziness. Refrain from driving if you experience these effects.
KidneySAFE IF PRESCRIBED
The use of Alprotic 133.5mg/58mg CR tablets in individuals with kidney conditions is likely safe. Preliminary evidence indicates dose modification may be unnecessary. Nevertheless, it's crucial to seek medical advice. Patients with pre-existing kidney disease should discuss this medication with their physician.
LiverCAUTION
Patients with liver impairment should exercise caution when using Alprotic 133.5mg/58mg CR tablets. Dosage modification may be necessary. Physician consultation is advised. Alprotic 133.5mg/58mg CR tablets are contraindicated in patients with severe or active liver disease.
What if you forget to take Alprotic 133.5mg/58mg Tablet CR :
Should you forget a dose of Alprotic 133.5mg/58mg CR Tablet, administer it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Alprotic 133.5mg/58mg Tablet CR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Neuroscience of the Central Nervous System |
